全文获取类型
收费全文 | 2841篇 |
免费 | 203篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 137篇 |
妇产科学 | 60篇 |
基础医学 | 330篇 |
口腔科学 | 25篇 |
临床医学 | 394篇 |
内科学 | 598篇 |
皮肤病学 | 33篇 |
神经病学 | 241篇 |
特种医学 | 52篇 |
外科学 | 312篇 |
综合类 | 38篇 |
一般理论 | 3篇 |
预防医学 | 381篇 |
眼科学 | 102篇 |
药学 | 192篇 |
肿瘤学 | 137篇 |
出版年
2024年 | 8篇 |
2023年 | 31篇 |
2022年 | 32篇 |
2021年 | 62篇 |
2020年 | 62篇 |
2019年 | 78篇 |
2018年 | 77篇 |
2017年 | 64篇 |
2016年 | 50篇 |
2015年 | 72篇 |
2014年 | 105篇 |
2013年 | 128篇 |
2012年 | 181篇 |
2011年 | 240篇 |
2010年 | 119篇 |
2009年 | 102篇 |
2008年 | 159篇 |
2007年 | 200篇 |
2006年 | 194篇 |
2005年 | 160篇 |
2004年 | 150篇 |
2003年 | 149篇 |
2002年 | 147篇 |
2001年 | 45篇 |
2000年 | 39篇 |
1999年 | 30篇 |
1998年 | 28篇 |
1997年 | 21篇 |
1996年 | 17篇 |
1995年 | 15篇 |
1994年 | 14篇 |
1993年 | 12篇 |
1992年 | 23篇 |
1991年 | 21篇 |
1990年 | 21篇 |
1989年 | 12篇 |
1988年 | 14篇 |
1987年 | 19篇 |
1986年 | 12篇 |
1985年 | 13篇 |
1984年 | 11篇 |
1983年 | 9篇 |
1982年 | 7篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1977年 | 6篇 |
1976年 | 6篇 |
1974年 | 8篇 |
1973年 | 12篇 |
1970年 | 7篇 |
排序方式: 共有3047条查询结果,搜索用时 0 毫秒
991.
Adam C. Abraham Diego F. Villegas Kenton R. Kaufman Tammy L. Haut Donahue 《Journal of orthopaedic research》2013,31(10):1507-1513
This study investigated the internal fluid pressure of human cadaver meniscal root attachments. A pressure micro‐sensor was implanted inside each attachment site. Tibiofemoral joints were compressed to 2× body weight at various flexion angles and pressure recorded for 20 min. The anterior cruciate ligament (ACL) was then transected and joints retested. Lastly, a longitudinal incision of the lateral posterior (LP) horn was made and the joint retested. Ramp pressure was defined as the pressure when 2× body weight was reached, and equilibrium pressure was recorded at the end of the hold period. The medial posterior (MP) attachment was subjected to greater ramp pressure than the medial anterior (p = 0.002) and greater equilibrium pressure than all other root attachment sites (p < 0.001). Flexion angle had a significant effect on pressure as full extension was greatest at ramp (p = 0.040). Transection of the ACL decreased ramp pressure in the LP attachment (p = 0.025) and increased equilibrium pressure (p = 0.031) in the MP attachment. The results suggest that repair strategies should be developed which reconstruct the MP attachments to be sufficient to withstand large pressures. Furthermore, since meniscal pressure is highest at full extension, this fact should be considered when prescribing rehabilitation following repair of an attachment. © 2013 Orthopaedic Research Society Published by Wiley Periodicals, Inc. J Orthop Res 31:1507–1513, 2013 相似文献
992.
EJ Rowin BJ Maron E Appelbaum MS Link CM Gibson JR Lesser TS Haas JE Udelson WJ Manning MS Maron 《The American journal of cardiology》2012,110(7):1027-1032
Preparticipation screening of athletes with 12-lead electrocardiography has been promoted for the detection of asymptomatic cardiovascular disease, particularly hypertrophic cardiomyopathy (HC). Although false-positive electrocardiographic (ECG) results for HC are well recognized in athlete screening, expected false-negative rates are unknown. The aim of this study was to characterize the rate of false-negative ECG findings in a cohort of young asymptomatic patients with phenotypically expressed HC, defined by cardiovascular magnetic resonance, using the 2010 European Society of Cardiology recommended ECG criteria for the identification of suspected heart disease in trained athletes. Cardiac magnetic resonance studies and 12-lead electrocardiography were performed in 114 consecutive asymptomatic patients with HC aged ≤35 years (mean age 22 ± 8 years; 77% male patients). Electrocardiograms were analyzed to distinguish pathologic ECG patterns from alterations considered nonpathologic and physiologic consequences of athletic training. Among the 114 patients with HC, 103 (90%) demonstrated ≥1 pathologic ECG abnormality, while the remaining 11 patients (10%) had normal or nonpathologic ECG patterns and therefore defined a subgroup in whom ECG screening would not be expected to raise suspicion of heart disease (i.e., false-negative results). In this false-negative ECG results group, maximal left ventricular wall thickness was 17 ± 2 mm (range 15 to 21), compared to patients with pathologic ECG patterns, in whom maximal left ventricular wall thickness was 22 ± 5 mm (p = 0.003). In conclusion, a substantial minority of young asymptomatic patients with HC with phenotypically expressed left ventricular hypertrophy have nonpathologic ECG findings on the basis of the 2010 European Society of Cardiology guidelines. In principle, this high false-negative rate of 10% represents an important limitation in applying 12-lead electrocardiography to large, apparently healthy athletic populations for the detection of HC. 相似文献
993.
Veenstra-VanderWeele J Muller CL Iwamoto H Sauer JE Owens WA Shah CR Cohen J Mannangatti P Jessen T Thompson BJ Ye R Kerr TM Carneiro AM Crawley JN Sanders-Bush E McMahon DG Ramamoorthy S Daws LC Sutcliffe JS Blakely RD 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(14):5469-5474
Fifty years ago, increased whole-blood serotonin levels, or hyperserotonemia, first linked disrupted 5-HT homeostasis to Autism Spectrum Disorders (ASDs). The 5-HT transporter (SERT) gene (SLC6A4) has been associated with whole blood 5-HT levels and ASD susceptibility. Previously, we identified multiple gain-of-function SERT coding variants in children with ASD. Here we establish that transgenic mice expressing the most common of these variants, SERT Ala56, exhibit elevated, p38 MAPK-dependent transporter phosphorylation, enhanced 5-HT clearance rates and hyperserotonemia. These effects are accompanied by altered basal firing of raphe 5-HT neurons, as well as 5HT(1A) and 5HT(2A) receptor hypersensitivity. Strikingly, SERT Ala56 mice display alterations in social function, communication, and repetitive behavior. Our efforts provide strong support for the hypothesis that altered 5-HT homeostasis can impact risk for ASD traits and provide a model with construct and face validity that can support further analysis of ASD mechanisms and potentially novel treatments. 相似文献
994.
995.
Uric acid is associated with cardiovascular disease and cardiovascular disease risk factors in adults, including chronic kidney disease, coronary artery disease, stroke, diabetes mellitus, preeclampsia, and hypertension. We examined the association between uric acid and elevated blood pressure in a large, nationally representative cohort of US adolescents, a population with a relatively low prevalence of cardiovascular disease and cardiovascular disease risk factors. Among 6036 adolescents 12 to 17 years of age examined in the 1999-2006 National Health and Nutrition Examination Survey, the mean age was 14.5 years, 17% were obese (body mass index: ≥95th percentile), and 3.3% had elevated blood pressure. Mean serum uric acid level was 5.0 mg/dL, and 34% had a uric acid level ≥5.5 mg/dL. In analyses adjusted for age, sex, race/ethnicity, and body mass index percentile, the odds ratio of elevated blood pressure, defined as a systolic or diastolic blood pressure ≥95th percentile for age, sex, and height, for each 0.1-mg/dL increase in uric acid level was 1.38 (95% CI: 1.16-1.65). Compared with <5.5 mg/dL, participants with a uric acid level ≥5.5 mg/dL had a 2.03 times higher odds of having elevated blood pressure (95% CI: 1.38-3.00). In conclusion, increasing levels of serum uric acid are associated with elevated blood pressure in healthy US adolescents. Additional prospective studies and clinical trials are needed to determine whether uric acid is merely a marker in a complex metabolic pathway or causal of hypertension and, thus, a potential screening and therapeutic target. 相似文献
996.
997.
Harris ES Smith TL Springett GM Weyrich AS Zimmerman GA 《American journal of hematology》2012,87(3):311-313
Leukocyte adhesion deficiencies are rare clinical syndromes of impaired host defense that provide novel insights into regulation of immune and inflammatory responses. Leukocyte adhesion deficiency (LAD)-I variant (LAD-Iv), also called LAD-III, is a unique disorder in which inside-out signaling of β?, β?, and β? integrins on leukocytes and platelets is disrupted, leading to impaired cellular adhesion, recurrent infections, and bleeding. We originally reported the second patient with this disorder to be identified and characterized the adhesive deficiencies and functional phenotype of this subject's leukocytes. Here, we show that the molecular defect in this index subject is a new mutation in FERMT3 (KINDLIN-3) which encodes KINDLIN-3, a cytoskeletal protein that interacts with the cytoplasmic tails of β?, β?, and β? integrins and is required for inside-out and outside-in signaling of these heterodimers. We also report clinical features and previously unrecognized defects in cells from a new patient, a sibling of the original subject that we described who carries the same FERMT3 mutation. Mutations in FERMT3 have now been shown to be the basis for LAD-Iv/LAD-III in each of the four original patients or families that established this syndrome, including the family that we describe. 相似文献
998.
999.
1000.